NEW 2026 Essentials of Addiction Psychotherapy Course

Richard A. Rawson, Ph.D., is a Research Professor at the Vermont Center for Behavior and Health at the University of Vermont and a Professor Emeritus at the UCLA Department of Psychiatry. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. Dr. Rawson conducted numerous clinical trials on pharmacological and psychosocial/behavioral addiction treatments for the treatment of individuals with cocaine and methamphetamine disorders. He has led addiction research and training projects for the United Nations, the World Health Organization and the U.S. State Department, exporting science-based knowledge to many parts of the world. He is a member of the Motivational Incentives Policy Group, a volunteer group that is working to reduce obstacles to the use of contingency management for treatment of stimulant use disorder. He is currently providing technical assistance to 8 states on the development of treatment services for individuals with stimulant use disorder. He was recently awarded the ASAM Presidential Award for Excellence in Teaching and Leadership in Addiction Medicine and made a Distinguished Fellow by the International Society of Addiction Medicine. Dr. Rawson has published 3 books, 40 book chapters, and over 250 peer-reviewed articles and has conducted approximately a zillion workshops, paper presentations, and training sessions.

Bio goes here.

Brian Hurley, MD, MBA, DFASAM, FAPA is an addiction physician and the Medical Director of the Bureau of Substance Abuse Prevention and Control in the Los Angeles County Department of Public Health and a volunteer assistant clinical professor of addiction medicine in the UCLA Department of Family Medicine. He is the Immediate Past President of the American Society of Addiction Medicine. He is a Primary Investigator for the Centers for Disease Control Overdose to Action:LOCAL award to Los Angeles County. He is a member of the Motivational Interviewing Network of Trainers.

Dr. Brian Kiluk is Associate Professor of Psychiatry at Yale School of Medicine and Director of the Yale Psychotherapy Development Center conducting research that aims to improve treatments for substance use and addiction. He earned a Ph.D. in Clinical Psychology in 2009 from the University of Maryland, Baltimore County, followed by postdoctoral training in addictions treatment research at Yale, where he has remained for the past 15 years. His primary area of research focuses on the development, enhancement, and dissemination of evidence-based treatments for substance use disorders, specifically Cognitive Behavioral Therapy (CBT), and includes the evaluation of a novel digital version of CBT known as CBT4CBT. He has led efforts to expand access to CBT for substance use disorders through digital therapeutics, as well as the identification of factors that moderate its effectiveness and the mechanisms that promote behavior change.

His work has been consistently funded through research grants from the National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, serving as Principal Investigator on multiple projects, with total funding over $13 million. He has published over 100 peer-reviewed journal articles and book chapters and been an invited speaker at national and international conferences.

Dr. Kiluk also holds leadership roles within the Yale Department of Psychiatry as co-Director of an NIH-funded T32 Postdoctoral Fellowship, and as Director of Evidence-based Research and Training for the Yale Doctoral Internship, providing support and mentorship to the next generation of clinician-scientists. Lastly, as a nationally recognized expert in CBT, Dr. Kiluk consults with treatment facilities across the US to provide workshop training, as well as ongoing fidelity monitoring and coaching in the delivery of CBT.

Dr. King is a licensed psychologist with a Doctorate in Clinical and School Psychology from the Ferkauf Graduate School of Psychology at Yeshiva University. Dr. King hosted the Beyond Addiction Show, a weekly podcast dedicated to disseminating information about evidence-based treatments and interviewing people who have worked to move the conversation about substance use forward. Dr. King currently oversees the Day Program, CMC’s intensive outpatient treatment program. He is an Invitation to Change Trainer and has trained throughout the United States and in Uganda. He is a specialist in Dialectical Behavior Therapy (DBT), Cognitive Behavioral Treatment for Insomnia (CBT-I) and Acceptance and Commitment Therapy (ACT). He co-authored a chapter in Different Patients, Different Therapies (Cabaniss & Holoshitz, 2019) on using ACT to work with substance use disorders. 

John J. Mariani, MD is an Associate Professor of Clinical Psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and a Research Psychiatrist at the New York State Psychiatric Institute (NYSPI). Dr. Mariani is the Director of the Substance Treatment and Research Service (STARS) in the Division on Substance Use Disorders at the NYSPI/Columbia University Irving Medical Center. Dr. Mariani attended the New York University School of Medicine, completed a psychiatry residency at the Beth Israel Medical Center/Albert Einstein College of Medicine, and an addiction psychiatry clinical and research fellowship at Columbia University Medical Center and the New York State Psychiatric Institute. He serves on the board of the American Academy of Addiction Psychiatry and is the medical advisor to the Major League Baseball Players Association. Dr. Mariani’s research is focused on the development of novel medication treatments for substance use disorders and related co-occurring psychiatric disorders. He has received grant funding from the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as well as private foundations. Dr. Mariani has over 50 peer-reviewed scientific publications, in addition to a dozen book chapters on the treatment of substance use disorders.